Skip to main content

Recombinant Proteins/Peptides

Drive your development forward with our specialized services for recombinant proteins and peptide therapeutics. With a dedicated focus on analytics and unbiased, high-quality insights, we provide objective data analysis and tailored solutions that address the unique challenges of both recombinant proteins and peptides at every stage of development.
Contact Us
Abstract digital illustration of a DNA strand with blue and pink molecules. The image is a representation of the building blocks of life.

Our recombinant proteins/peptides offerings

Patients worldwide rely on your impactful treatments. Rely on Labcorp to help overcome the unique challenges of recombinant protein and peptide therapeutic development with our biopharmaceutical CMC services.

Analytical characterization

Comprehensive testing for identity, purity, potency and stability, including glycosylation profiling and impurity analysis

Formulation development

Optimized formulation strategies to enhance stability, solubility and bioavailability

Analytical method development

Robust methods for quantification, impurity profiling, stability testing and structural characterization, including glycosylation and aggregation analysis for proteins

Regulatory compliance support

Detailed CMC documentation and regulatory guidance aligned with global standards for biologics

Quality assurance

Rigorous quality systems to enable reproducibility and adherence to cGMP standards

Technology transfer

Smooth transition of methods from your labs to ours, minimizing risk and accelerating timelines

Resources

Article

Forced degradation of biopharmaceuticals: Protein stress testing

View Article

Info Sheet

Released N-glycan analysis of the Fc-fusion protein aflibercept with additional site-specific population and occupancy

Read Info Sheet

Article

Identification and quantification of host cell proteins in biopharmaceutical products

Read Article